China-made injectable PD-L1 drug flunks pivotal trial, forcing US partner to seek strategic options aliu Tue, 07/02/2024 – 16:06 More: China-made injectable PD-L1 drug flunks pivotal trial, forcing US partner to seek strategic options Source: fierce
read moreEmergent BioSolutions bags $250M in contract modifications to help boost US supply of medical countermeasures zbecker Tue, 07/02/2024 – 15:07 More: Emergent BioSolutions bags 0M in contract modifications to help boost US supply of medical countermeasures Source: fierce
read moreGame on: Lilly’s Alzheimer’s drug Kisunla, a challenger to Biogen and Eisai’s Leqembi, gains full FDA nod esagonowsky Tue, 07/02/2024 – 14:04 More: Game on: Lilly's Alzheimer's drug Kisunla, a challenger to Biogen and Eisai's Leqembi, gains full FDA nod
read moreHigh-flying Samsung Biologics inks $1B production pact with unnamed US pharma fkansteiner Tue, 07/02/2024 – 13:44 More: High-flying Samsung Biologics inks B production pact with unnamed US pharma Source: fierce
read moreBIOSECURE Act hurts US biopharma industry’s confidence in Chinese partners: survey aliu Tue, 07/02/2024 – 13:05 More: BIOSECURE Act hurts US biopharma industry's confidence in Chinese partners: survey Source: fierce
read more
Affecting around 3,755 young people in the UK every year, leukaemia is the most commonly diagnosed cancer in children More: Researchers find whole genome sequencing improves care for paediatric cancer Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals